Hepion Pharmaceuticals, Inc. (CTRVP) SEC Filings — 2025

Filings

• Hepion Pivots to Diagnostics, Cuts R&D Spend, Boosts Cash — 10-Q · Nov 12, 2025
• Hepion Pivots to Diagnostics, Divests Rencofilstat Amidst Rising Losses — 10-Q · Aug 14, 2025
• Hepion Pharma Appoints New Officers, Clinical Data Expected Q3 — 8-K · Jun 30, 2025
• Hepion Pharmaceuticals Files 8-K on Shareholder Vote Matters — 8-K · Jun 12, 2025
• Hepion Pharmaceuticals Announces Board and Compensation Changes — 8-K · Jun 9, 2025
• Hepion Pharmaceuticals Enters Material Definitive Agreement — 8-K · May 30, 2025
• Hepion Pharmaceuticals Files Q1 2025 10-Q — 10-Q · May 19, 2025
• Hepion Pharmaceuticals Faces Delisting Notice — 8-K · May 12, 2025
• Hepion Pharmaceuticals Files 8-K: Material Agreement & Equity Sales — 8-K · May 6, 2025
• Hepion Pharmaceuticals Files Definitive Proxy Statement — DEF 14A · Apr 28, 2025
• Hepion Pharmaceuticals Faces Delisting Notice — 8-K · Apr 17, 2025
• Hepion Pharmaceuticals Files 2024 10-K — 10-K · Apr 8, 2025
• Hepion Pharmaceuticals Files 8-K/A Amendment — 8-K/A · Apr 4, 2025
• Hepion Pharmaceuticals Faces Delisting Notice — 8-K · Mar 20, 2025
• Hepion Pharmaceuticals Files 8-K on Security Holder Rights — 8-K · Mar 19, 2025
• Hepion Pharmaceuticals Files 8-K on Security Holder Vote — 8-K · Mar 10, 2025
• Hepion Pharmaceuticals Files 8-K — 8-K · Mar 4, 2025
• Hepion Pharmaceuticals Files Definitive Proxy Statement — DEF 14A · Feb 7, 2025
• Hepion Pharmaceuticals Faces Delisting Notice — 8-K · Jan 15, 2025
• Hepion Pharmaceuticals Files S-1/A Amendment — S-1/A · Jan 14, 2025
• Hepion Pharmaceuticals Files 2023 Annual Report Amendment — 10-K/A · Jan 13, 2025